肺炎支原体肺炎的研究进展

Research progress on mycoplasma pneumoniae pneumonia

肺炎是全球小儿死亡的最常见原因,随着肺炎相关疫苗的使用,肺炎支原体逐渐成为小儿肺炎最常见的病原之一,影响着全球儿童的健康。肺炎支原体肺炎的诊断需要结合临床、X线、实验室检查,其发病与肺炎支原体对机体的直接损伤以及机体的自身免疫有关。肺炎支原体肺炎常被认为是一种自限性疾病,而随着对肺炎支原体肺炎的研究的深入,发现耐药肺炎支原体菌株逐渐增多,重症肺炎支原体肺炎、难治性肺炎支原体肺炎的发病率也在不断的增加,临床治疗难度也在不断的增加,严重后遗症的发生率较高,需要引起广大儿科医师的重视。

Pneumonia is the common cause of death in children in the world.With the use of pneumonia-related vaccine,mycoplasma pneumoniae has gradually become one of the common pathogens of pneumonia,which affects the health of children.The diagnosis of mycoplasma pneumoniae pneumonia requires comprehensive consideration of clinical symptoms,X-ray,and laboratory examinations.The pathogenesis is related to the direct invasion of mycoplasma pneumoniae and the human immunity.Although mycoplasma pneumoniae pneumonia is generally considered to be a self-limiting disease,with the further researches about mycoplasma pneumoniae pneumonia,it is found that macrolide-resistant strains of mycoplasma pneumoniae have increased gradually,and the incidence of severe mycoplasma pneumoniae pneumonia and refractory mycoplasma pneumoniae pneumonia is also increasing.Therefore,the difficulty of treatment of mycoplasma pneumoniae pneumonia is increasing,and the incidence of serious sequelaes is relatively higher,which needs to be paid much attention by the pediatricians.